NCT05760807 - Intranasal Oxytocin for Methamphetamine Withdrawal in Women | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 29, 2023

Primary Completion Date

March 28, 2024

Study Completion Date

March 28, 2024

Conditions

Methamphetamine Use Disorder

Interventions

DRUG

Oxytocin nasal spray

Intranasal oxytocin, administered dose 24 international units (IU) twice daily, delivered over 7 days of a residential inpatient withdrawal admission.

Trial Locations (1)

3121

Turning Point, Richmond